Ronald H B Meyboom1, I Ralph Edwards. Show Affiliations » 1. Department of Pharmacoepidemiology, Faculty of Pharmaceutical Sciences, Utrecht University, 3508 TB Utrecht, Netherlands. r.meyboom@who-umc.org
Abstract
Entities: Chemical
Mesh: See more » Adverse Drug Reaction Reporting SystemsDrug IndustryEuropean UnionFluorobenzenes/adverse effectsHumansHydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effectsMarketingProduct Surveillance, PostmarketingPyrimidines/adverse effectsRhabdomyolysis/chemically inducedRosuvastatin CalciumSafetySulfonamides/adverse effectsUnited Kingdom
Substances: See more » FluorobenzenesHydroxymethylglutaryl-CoA Reductase InhibitorsPyrimidinesSulfonamidesRosuvastatin Calcium
Year: 2004 PMID: 15582043 DOI: 10.1016/S0140-6736(04)17525-9
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321